Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Journal of Clinical Medicine|April 3, 2021
Quality of Life and Psychological Impact in Patients with Atopic DermatitisMarina Talamonti, Marco Galluzzo, Dionisio Silvaggio, et al.Expert Opinion on Biological Therapy|December 28, 2019
In which patients the best efficacy of secukinumab? Update of a real-life analysis after 136 weeks of treatment with secukinumab in moderate-to-severe plaque psoriasisMarco Galluzzo, Simone D'Adamio, Dionisio Silvaggio, et al.Expert Opinion on Biological Therapy|November 27, 2020
Impact of secukinumab on patient-reported outcomes in moderate to severe plaque psoriasis: a review of clinical studiesMarco Galluzzo, Marina Talamonti, Valeria Manfreda, et al.Journal of Clinical Medicine|July 15, 2020
Use of Guselkumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A 1 Year Real-Life StudyMarco Galluzzo, Lorenzo Tofani, Paolo Lombardo, et al.Dermatology Reports|June 3, 2025
Severe paradoxical generalized pustular psoriasis induced by adalimumab biosimilar successfully treated with brodalumabAngela Fico, Edoardo Mortato, Claudia Paganini, et al.Dermatologic Therapy|July 27, 2020
Efficacy of Vismodegib in pigmented basal cell carcinoma: Appearances are deceivingCosimo Di Raimondo, Mauro Mazzeo, Monia Di Prete, et al.The Australasian Journal of Dermatology|October 11, 2020
Cutaneous mastocytosis: A dermatological perspectiveCosimo Di Raimondo, Ester Del Duca, Dionisio Silvaggio, et al.International Journal of Dermatology|July 2, 2021
Baseline neutrophil/lymphocyte ratio (NLR) and red blood cell distribution width (RDW) correlate with advanced stages in cutaneous squamous cell carcinomaCosimo Di Raimondo, Raffaele Dante Caposiena Caro, Diana Spallone, et al.Journal of Clinical Medicine|February 3, 2021
The Effects of Association of Topical Polydatin Improves the Preemptive Systemic Treatment on EGFR Inhibitors Cutaneous Adverse ReactionsMauro Bavetta, Dionisio Silvaggio, Elena Campione, et al.Pageof 1